UB Paderborn / Katalog / Suche / in CDI

Chimeric antigen receptor‐T cell therapy shows similar efficacy and toxicity in patients with diffuse large B‐cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study

HemaSphere, 2024-03, Vol.8 (3), p.e54-n/a

2024

Volltextzugriff (PDF)

Prevalence and clinical impact of CD56 and T‐cell marker expression in acute myeloid leukaemia: A single‐centre retrospective analysis

EJHaem, 2024-02, Vol.5 (1), p.93-104

2024

Volltextzugriff (PDF)

PB2413: SALVAGE THERAPY WITH VENETOCLAX AND A HYPOMETHYLATING AGENT FOR PATIENTS WITH AML RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

HemaSphere, 2023-08, Vol.7 (S3), p.e43727c0-n/a

2023

Volltextzugriff (PDF)

Comparable Survival for Fludarabine and Treosulfan Vs. Fludarabine and TBI As Conditioning Regimens in Patients with AML and MDS Undergoing Allogeneic Stem Cell Transplantation

Blood, 2023-11, Vol.142 (Supplement 1), p.3535-3535

2023

Volltextzugriff (PDF)

Blast Clearance after High Dose-Melphalan Conditioning for Allogeneic Stem Cell Transplantation in Relapsed and Refractory Acute Myeloid Leukemia

Blood, 2023-11, Vol.142 (Supplement 1), p.4911-4911

2023

Volltextzugriff (PDF)

TIM-3 Inhibitor Sabatolimab for Patients with Acute Myeloid Leukemia (AML) with Measurable Residual Disease (MRD) Detected after Allogeneic Stem Cell Transplantation (AlloSCT): Preliminary Findings from the Phase Ib/II Stimulus-AML2 Study

Blood, 2023-11, Vol.142 (Supplement 1), p.59-59

2023

Volltextzugriff (PDF)

Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients

Bone marrow transplantation (Basingstoke), 2024-08, Vol.59 (8), p.1097-1106

2024

Volltextzugriff (PDF)

Treosulfan-Based Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Myelodysplastic Syndrome (MDS): Promising Survival Outcome Including Patients with High-Risk Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.7587-7588

2022

Volltextzugriff (PDF)

Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia

British journal of haematology, 2024-07, Vol.205 (1), p.280-290

2024

Volltextzugriff (PDF)

137 - Treosulfan-Based Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) for Patients with Myelodysplastic Syndrome (MDS): Promising Survival Outcome Including Patients with High-Risk Disease

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S110-S111

2023

Volltextzugriff (PDF)

Treosulfan-Based Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) for Patients with Myelodysplastic Syndrome (MDS): Promising Survival Outcome Including Patients with High-Risk Disease

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S110-S111

2023

Volltextzugriff (PDF)

Characteristics and Outcome of Elderly Patients (> 55 Years) with Acute Lymphoblastic Leukemia (ALL)

Blood, 2021-11, Vol.138 (Supplement 1), p.3365-3365

2021

Volltextzugriff (PDF)

Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia

Annals of hematology, 2021-02, Vol.100 (2), p.587-589

2021

Volltextzugriff (PDF)

Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia

Bone marrow transplantation (Basingstoke), 2020-07, Vol.55 (7), p.1410-1420

2020

Volltextzugriff (PDF)

Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia

Cancers, 2022-01, Vol.14 (3), p.565

2022

Volltextzugriff (PDF)

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

The Lancet. Haematology, 2024-05, Vol.11 (5), p.e324-e335

2024

Volltextzugriff (PDF)

IMG/VR v3: an integrated ecological and evolutionary framework for interrogating genomes of uncultivated viruses

Nucleic acids research, 2021-01, Vol.49 (D1), p.D764-D775

2021

Volltextzugriff (PDF)

Do preservice teachers believe they use the Australian Professional Standards for Teachers to inform their professional learning?

The Australian journal of teacher education, 2021-06, Vol.46 (6), p.98-114

2021

Volltextzugriff (PDF)

Fission‐Fusion Dynamics: New Research Frameworks

Current anthropology, 2008-08, Vol.49 (4), p.627-654

2008

Volltextzugriff (PDF)

Materials-Related Aspects of Thermochemical Water and Carbon Dioxide Splitting: A Review

Materials, 2012-11, Vol.5 (11), p.2015-2054

2012

Volltextzugriff (PDF)

Reports of insurance-based discrimination in health care and its association with access to care

American journal of public health (1971), 2015-07, Vol.105 Suppl 3 (S3), p.S517-S525

2015

Volltextzugriff (PDF)

IMG/VR v4: an expanded database of uncultivated virus genomes within a framework of extensive functional, taxonomic, and ecological metadata

Nucleic acids research, 2023-01, Vol.51 (D1), p.D733-D743

2023

Volltextzugriff (PDF)

Reducing firearm access for youth at risk for suicide in a pediatric emergency department

Frontiers in public health, 2024-05, Vol.12, p.1352815-1352815

2024

Volltextzugriff (PDF)

Blimp-1/PRDM1 and Hr3/RORβ specify the blue-sensitive photoreceptor subtype in Drosophila by repressing the hippo pathway

Frontiers in cell and developmental biology, 2023-03, Vol.11, p.1058961-1058961

2023

Volltextzugriff (PDF)

Contrasting Evolutionary Patterns Between Sexual and Asexual Lineages in a Genomic Region Linked to Reproductive Mode Variation in the pea aphid

Genome biology and evolution, 2023-09, Vol.15 (9), p.1-18

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Chimeric antigen receptor‐T cell therapy shows similar efficacy and toxicity in patients with diffuse large B‐cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study

Prevalence and clinical impact of CD56 and T‐cell marker expression in acute myeloid leukaemia: A single‐centre retrospective analysis

PB2413: SALVAGE THERAPY WITH VENETOCLAX AND A HYPOMETHYLATING AGENT FOR PATIENTS WITH AML RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

Comparable Survival for Fludarabine and Treosulfan Vs. Fludarabine and TBI As Conditioning Regimens in Patients with AML and MDS Undergoing Allogeneic Stem Cell Transplantation

Blast Clearance after High Dose-Melphalan Conditioning for Allogeneic Stem Cell Transplantation in Relapsed and Refractory Acute Myeloid Leukemia

TIM-3 Inhibitor Sabatolimab for Patients with Acute Myeloid Leukemia (AML) with Measurable Residual Disease (MRD) Detected after Allogeneic Stem Cell Transplantation (AlloSCT): Preliminary Findings from the Phase Ib/II Stimulus-AML2 Study

Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients

Treosulfan-Based Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Myelodysplastic Syndrome (MDS): Promising Survival Outcome Including Patients with High-Risk Disease

Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia

137 - Treosulfan-Based Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) for Patients with Myelodysplastic Syndrome (MDS): Promising Survival Outcome Including Patients with High-Risk Disease

Treosulfan-Based Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) for Patients with Myelodysplastic Syndrome (MDS): Promising Survival Outcome Including Patients with High-Risk Disease

Characteristics and Outcome of Elderly Patients (> 55 Years) with Acute Lymphoblastic Leukemia (ALL)

Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia

Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia

Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

IMG/VR v3: an integrated ecological and evolutionary framework for interrogating genomes of uncultivated viruses

Do preservice teachers believe they use the Australian Professional Standards for Teachers to inform their professional learning?

Fission‐Fusion Dynamics: New Research Frameworks

Materials-Related Aspects of Thermochemical Water and Carbon Dioxide Splitting: A Review

Reports of insurance-based discrimination in health care and its association with access to care

IMG/VR v4: an expanded database of uncultivated virus genomes within a framework of extensive functional, taxonomic, and ecological metadata

Reducing firearm access for youth at risk for suicide in a pediatric emergency department

Blimp-1/PRDM1 and Hr3/RORβ specify the blue-sensitive photoreceptor subtype in Drosophila by repressing the hippo pathway

Contrasting Evolutionary Patterns Between Sexual and Asexual Lineages in a Genomic Region Linked to Reproductive Mode Variation in the pea aphid

Suchergebnisse filtern